| Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry RP Barbaro, G MacLaren, PS Boonstra, TJ Iwashyna, AS Slutsky, E Fan, ... The Lancet 396 (10257), 1071-1078, 2020 | 711 | 2020 |
| Implementation of high-flow nasal cannula therapy outside the intensive care setting JA Jackson, SK Spilman, LK Kingery, TW Oetting, MJ Taylor, WM Pruett, ... Respiratory Care 66 (3), 357-365, 2021 | 23 | 2021 |
| Lethal fungemia in COVID-19 pneumonia A Plemmons, W Pruett, J Macaraeg Chest 160 (4), A430, 2021 | 3 | 2021 |
| Secondary HLH presenting as ARDS W Pruett, A Plemmons, M Sanley Chest 158 (4), A1979, 2020 | 2 | 2020 |
| A Retrospective Analysis of the Effects of Time on Compliance and Driving Pressures in ARDS N Jagan, LE Morrow, RW Walters, RW Plambeck, I Ng, JJ Chovatiya, ... Respiratory care 68 (1), 52-59, 2023 | 1 | 2023 |
| Pharmacotherapy considerations in hospitalized patients with COVID-19 pneumonia W Pruett, MA Malesker US Pharmacist 45, HS-9, 2020 | 1 | 2020 |
| Use of nasal high flow oxygen on the general medical floor can prevent ICU admission and escalation of care in COPD patients K Branick, JA Jackson, D McCann, CA Pelaez, WM Pruett, SK Spilman, ... B24. CRITICAL CARE: GONE WITH THE WIND-MECHANICAL VENTILATION: HFNC, NIV AND …, 2019 | 1 | 2019 |
| Factors Associated with Emergency Department Admission in COPD Exacerbations WM Pruett, H Smith, C Ellis C42. CONTEMPORARY TOPICS IN COPD, A4963-A4963, 2018 | 1 | 2018 |
| A RARE CASE OF SEPTIC CARDIOMYOPATHY AND LEFT VENTRICULAR THROMBUS INDUCED BY STREPTOCOCCAL TOXIC SHOCK SYNDROME P Fahim, M Goldfarb, WM Pruett, RW Plambeck Chest 164 (4), A2041-A2042, 2023 | | 2023 |
| STABLE TO SHOCK: CAPTURING THE CHAOS OF A FATAL SPONTANEOUS HEMOTHORAX IN NEUROFIBROMATOSIS TYPE 1 E TEPLITSKY, M KHEDEKAR, R MCMAHON, IANP JACKSON, ... CHEST 164 (4), A3958-A3959, 2023 | | 2023 |
| COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic CJ Destache, F Ahmad, S Rajendrapasad, A Loranger, W Pruett, N Jagan, ... Pharmacy 10 (4), 69, 2022 | | 2022 |
| Comparison of the performance of a clinical classification tree versus clinical gestalt in predicting sepsis with extended-spectrum beta-lactamase–producing gram-negative rods HL Smith, MA Elfeki, D Lowry, R Sabates, M Ropte, KR Sittig, S Finch, ... Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e35, 2022 | | 2022 |
| Oral inhaled medications—beyond bronchodilators W Pruett, BE Perman, LE Morrow, MA Malesker US Pharm 7 (46), 4-12, 2021 | | 2021 |
| 216: COVID-19 Therapeutics: What Works? S Rajendraprasad, F Ahmad, A Loranger, W Pruett, B Kessel, N Jagan, ... Critical Care Medicine 49 (1), 93, 2021 | | 2021 |
| 231: Influence of Health Disparities on COVID-19 Critical Care Admissions F Ahmad, S Rajendraprasad, A Loranger, W Pruett, B Kessel, N Jagan, ... Critical Care Medicine 49 (1), 101, 2021 | | 2021 |
| Primary Pulmonary Lymphoma Presenting as ARDS WM Pruett, BJ Krajicek, LE Morrow A44. CRITICAL CARE CASE REPORTS: HEMATOLOGY AND ONCOLOGY, A1712-A1712, 2020 | | 2020 |
| Tissue Plasminogen Activator and Dornase Alpha in the Treatment of Complicated Parapneumonic Effusions: An Institutional Retrospective Investigation WM Pruett, MW Trump, H Smith, R Flood, G Wall A107. CLINICAL AND TRANSLATIONAL INVESTIGATIONS INTO ACUTE RESPIRATORY …, 2018 | | 2018 |
